BioXcel Therapeutics (BTAI) Ends The Year On High Note, Stock Up Over 300%

Shares of BioXcel Therapeutics Inc. (BTAI) closed Tuesday, the last trading day of 2019, at $14.61, up a whopping 338% in the year.

from RTT - Biotech https://ift.tt/35joUAx
via IFTTT

Read More »

Activity May Be Subdued On Final Trading Day Of 2019

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday following the pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2QbbtOE
via IFTTT

Read More »

Universal Music sells stake to Chinese giant Tencent

Owner Vivendi to offload 10% stake worth €3bn with more deals likely to cash in on music revival

Universal Music Group, the home of stars including Taylor Swift, Lady Gaga and The Beatles, has sold a 10% stake to a consortium led by Chinese tech giant Tencent in a deal valuing the world’s largest music company at €30bn (€25bn).

UMG’s parent company, Vivendi, which is controlled by the French billionaire Vincent Bolloré, has also agreed that the Tencent-led consortium has the option to buy another stake of up to 10% at the same price by 15 January 2021.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2QbHAxt

Read More »

EyeGate Pharma (EYEG) Has Caught Investors' Eyes, Stock Up 300% In 3 Months

Shares of EyeGate Pharmaceuticals Inc. (EYEG), which closed at a new 52-week high of $12.20 on Monday, have gained an impressive 312% in the last three months.

from RTT - Biotech https://ift.tt/35bgIC3
via IFTTT

Read More »

ERYTECH Pharma (ERYP) Up 40% This Month, What Next?

French biotech ERYTECH Pharma S.A. (ERYP) has gained nearly 40% this month as the Company progresses with its lead product candidate Eryaspase, which is based on its proprietary ERYCAPS platform.

from RTT - Biotech https://ift.tt/39u8Kre
via IFTTT

Read More »

Biotech Stocks Facing FDA Decision In January 2020

A total of 48 novel drugs and biologics received FDA approval in 2019. Let's take a look at the FDA calendar of January 2020.

from RTT - Biotech https://ift.tt/2ZBHjqK
via IFTTT

Read More »

ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed

Today's Daily Dose brings you news about Aridis Pharma's collaboration with privately-held Mapp Biopharmaceutical; FDA approval for AZN/MRK's Lynparza for yet another indication; Axsome Therapeutics' continuing momentum; Sol-Gel's acne trial results; update on X4 Pharmaceuticals' Mavorixafor, and jail term for the Chinese scientist He Jiankui.

from RTT - Biotech https://ift.tt/36bXY6V
via IFTTT

Read More »